Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of FLT3 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB,ELISA,IHC-P |
More info about FLT3 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB17006 |
| Product name: | FLT3 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of FLT3. |
| Gene id: | 2322 |
| Gene name: | FLT3 |
| Gene alias: | CD135|FLK2|STK1 |
| Gene description: | fms-related tyrosine kinase 3 |
| Immunogen: | A synthetic peptide corresponding to residues surrounding Y591 of human FLT3. |
| Protein accession: | P36888 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:500-1:1000) Immunohistochemistry (1:50-1:100) ELISA (1:20000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In 20 mM PBS, 0.15 M NaCl, pH 7.2 (0.01% sodium azide) |
| Storage instruction: | Store at 4°C for three months. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Specificity: | This antibody detects endogenous levels of total FLT3 protein. |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using FLT3 polyclonal antibody (Cat # PAB17006). |
| Applications: | WB,ELISA,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy.Naoe T, Kiyoe H, Yamamoto Y, Minami Y, Yamamoto K, Ueda R, Saito H. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S27-30. |